Medicare could unlock a trove of valuable clinical trial data through relatively modest changes to reporting requirements, USC Schaeffer Scholars Sidra Haye and Mireille Jacobson write in @jamahealthforum.com.
More accurate reporting of trial-related care could generate valuable evidence about new treatments, promote representative trial enrollment and improve coverage decisions. - June 12, 2026
